We are live on
!
Find out more
FCMI
Foresite Capital Management II Portfolio holdings
AUM
$29.2M
1-Year Est. Return
44.84%
This Fund
S&P 500
This Quarter
Est. Return
+53.1%
1 Year Est. Return
+44.84%
3 Year Est. Return
-66.21%
5 Year Est. Return
-36.36%
10 Year Est. Return
–
AUM
$39.5M
AUM Growth
-$9.98M
(-20%)
Cap. Flow
-$30.4M
Cap. Flow
% of AUM
-76.79%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
1
New
–
Increased
–
Reduced
1
Closed
–
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
10x Genomics
TXG
|
+$30.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
Similar funds
AG
SAM
AC
QI
TAAM
NAM
MSKCC
BRC
Foresite Capital Management II's Q1 2023 Portfolio in Review
As of Q1 2023, Foresite Capital Management II held 1 position worth $39.5M, down 20% from $49.5M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Foresite Capital Management II withdrew a net $30.4M in Q1 2023, reducing 1 holding. Its largest reduction was 10x Genomics, cutting an estimated $30.4M.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.
- Foresite Capital Management II's biggest Q1 2023 reduction was 10x Genomics, cutting an estimated $30.4M.
- Foresite Capital Management II's ten largest holdings make up 100% of its $39.5M portfolio in Q1 2023.
- Foresite Capital Management II opened 0 new positions and closed 0 in Q1 2023.
- Foresite Capital Management II's portfolio value fell 20% quarter-over-quarter to $39.5M.
Based on Foresite Capital Management II's 13F filing for Q1 2023, filed 12 May 2023.